Self-assembled Nanoparticles Based on DNA Origami and a Nitrated T Helper Cell Epitope As a Platform for the Development of Personalized Cancer Vaccines

Yanliang Kang,Wanli Zhang,Qiumin Yu,Le Gao,Jiale Quan,Fangling Gu,Yuxin Wu,Yahong Tian,Zijie Wu,Shishuai Shao,Hongyou Zhou,Shukang Duan,Yixiang Zhou,Li Zhang,Xiangdong Gao,Hong Tian,Wenbing Yao

DOI: https://doi.org/10.1007/s00262-023-03446-y

IF: 6.63

2023-01-01

Cancer Immunology Immunotherapy

Abstract:Neoantigen vaccines constitute an emerging and promising cancer immunotherapy. However, not all neoantigens have anti-tumor activity, as poor CD4(+) epitope recognition can lead to the lack of greatly limit the persistence of the CD8(+) T cell response. Therefore, we designed a self-assembled nanoplatform hereinafter referred to as DNA-coupled nitrated T helper cell epitope nanoparticle (DCNP) based on DNA origami containing a nitrated CD4 + T cell epitope, which can facilitate the effective activation of neoantigen-specific CD8(+) T cells. Moreover, we embedded the cytidine-phosphate-guanosine oligonucleotide (CpG ODN) motif sequence in the DNA skeleton to function as a built-in adjuvant to activate Toll-like receptor 9. DCNP can markedly improve adjuvant and neoantigen co-delivery to lymphoid organs and promote neoantigen presentation on dendritic cells. Moreover, DCNP induced robust, and long-lived neoantigen-specific CD8(+) T cell responses that significantly delayed tumor growth. Further, these effects were largely dependent on the nitrated T cell epitope. Collectively, our findings indicate that DCNP is a promising platform that could improve the development of personalized therapeutic neoantigen vaccines for cancer immunotherapy.